Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Tu dai"'
Autor:
Yongping Zhou, Zhiyuan Hua, Ye Zhu, Liying Wang, Fangming Chen, Ting Shan, Yunhai Zhou, Tu Dai
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Pancreatic cancer is a highly malignant gastrointestinal cancer that can widely metastasize during the early stage of disease, and it is associated with one of the worst prognoses among cancers. In this study, we aimed to investig
Externí odkaz:
https://doaj.org/article/d829f8fd66cb4e9fa3f8dee8520c172d
Autor:
Yongping Zhou, Yonggang Huang, Tu Dai, Zhiyuan Hua, Jian Xu, Yuting Lin, Lulu Han, Xiong Yue, Lichen Ho, Jinjing Lu, Xiaoming Ai
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 111030- (2021)
Drug resistance has always been an important problem affecting the therapeutic effect of hepatocellular carcinoma (HCC). To investigate the potential role of lncRNA TTN-AS1 in HCC cells with sorafenib (SOR) resistance, and explore the underlying path
Externí odkaz:
https://doaj.org/article/2c46c868eda74bf8ac9d07831c5bc59d
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0164941 (2016)
Brain-derived neurotrophic factor (BDNF) protects retinal ganglion cells against ischemia in ocular degenerative diseases. We aimed to determine the effect of BDNF-AS on the ischemic injury of retinal ganglion cells.The levels of BDNF and BDNF-AS wer
Externí odkaz:
https://doaj.org/article/49e941a5dbe7482baae98442525d4856
Publikováno v:
Cell Biology International. 47:1081-1091
Publikováno v:
Materials Express. 13:222-229
Pancreatic cancer (PC) is a common malignancy that is characterized by strong invasiveness and rapid development. With lack of effective treatments, patients still suffer from poor outcome. In this study, we established liposomal nanoparticles carryi
Autor:
Kuan Li, Zhiyuan Hua, Hao Wang, Wuyang Bian, Yongping Zhou, Fangming Chen, Tu Dai, Hong Wang, Xuexia Zou
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 10862-10877 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 10862-10877 (2021)
Hepatocellular carcinoma (HCC) is a malignant tumor that seriously perils human health. Recent years have seen much effect in revealing the pathological association between lncRNA and HCC. Herein, we identified lncRNA DHRS4-AS1 as a potential tumor s
Autor:
Tu Dai, Xiaoming Ai, Yongping Zhou, Kuan Li, Fangming Chen, Zhiyuan Hua, Hong Wang, Hao Wang, Wuyang Bian
Publikováno v:
Aging (Albany NY)
Background: Multiple researches have revealed that long non-coding RNA (lncRNAs) served as regulatory factor in modulating tumorigenesis of hepatocellular carcinoma (HCC). In this study, we demonstrated that lncRNA HCP5 was a tumor promoting factor o
Publikováno v:
Journal of Cellular Physiology. 233:5805-5814
By investigating the migration and invasion ability in pancreatic cancer, this study probed into the lncRNA MALAT1 molecular mechanism on Hippo-YAP signaling. The expression of lncRNA MALAT1 in PC tissues and cells was detected by qRT-PCR and Western
Autor:
Tu Dai, Liying Wang, Yigang Chen, Zhiyuan Hua, Yongping Zhou, Haixin Qian, Ye Zhu, Wenzhou Ding
Publikováno v:
IUBMB Life. 70:276-290
This study was expected to reveal the regulatory effects of lncRNA UCA1 on pancreatic cancer cell progression through targeting miR-96/FOXO3. Microarray analysis was carried out on 36 cases of pancreatic cancer tissues and 16 cases of adjacent tissue
Publikováno v:
Oncotarget
// Hui Zhao 1, 3, * , Ye Hua 2, * , Zhihua Lu 1 , Shen Gu 3 , Laifa Zhu 1 , Yuan Ji 1 , Yudong Qiu 3 , Tu Dai 1 and Huihan Jin 1 1 Department of Hepatopancreatobiliary Surgery, Nanjing Medical University Affiliated Wuxi Second People’s Hospital, Wu